OncoNano Medicine Raises ~$50 Million
Financing round led by Advantech healthcare investment team Funds will support Phase 3 program for pegsitacianine and IND-enabling activities for ONM-501 OncoNano Medicine, Inc. today announced...
Tag : human clinical trials
Apollo Therapeutics Completes $145 Million Financing
Proceeds to support rapid advancement of pipeline with over 15 therapeutic programs currently in development across oncology, major inflammatory disorders and rare disease Company to...
Umoja Biopharma Closes an Oversubscribed $210 Million Series B
Series B financing co-led by SoftBank Vision Fund 2 and Cormorant Asset Management Financing accelerates development of Umoja’s pipeline of in vivo engineered CAR T...
RNA Medicines Developer Ochre Bio Closes $9.6M Seed Financing
Funding will be used to develop RNA therapies for transplant and chronic liver diseases Ochre Bio has built a deep phenotyping platform to identify novel...
Novel Drug Binders Developer RayzeBio Secures $108 Million
–Total raise of $258 million since company launch in August 2020– RayzeBio, Inc., which is discovering and developing a broad pipeline of innovative targeted radiopharmaceutical...
Alentis Therapeutics Raises USD 67 Million in Series B
Funding to Advance Pipeline of Anti-fibrotic Molecules into the Clinic Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, today announced that it...
TransPerfect Life Sciences Unveils AI-Powered TMF Automation
TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced its...
HiFiBiO Therapeutics Closes $75 Million Series D Financing
Latest funding led by Mirae Asset Financial Group and joined by B Capital Group, Sherpa, and other new investors together with existing investors such as...
Senda Biosciences Announces Closing of $98 Million Series B
Funding to accelerate development of its platform and therapeutic programs Senda Biosciences, a company that is systematically harnessing the powerful molecular interactions that have evolved...
Bright Peak Therapeutics Announces $107 Million Series B
–Proceeds to advance company’s pipeline of next-generation cytokine immunotherapies– –Laura Shawver, Christine Siu join as independent directors– Bright Peak Therapeutics, a biotechnology company developing next-generation...